Title: Constipation - Pipeline Review, H2 2015
1Constipation - Pipeline Review, H2 2015
(Type, Mode of action, Crop Type and Geography) -
Size, Share, Global Trends, Company Profiles,
Demand, Insights, Analysis, Research, Report,
Opportunities, Segmentation and Forecast, 2013 -
2020
TELEPHONE 1 (503) 894-6022E-MAIL
sales_at_researchbeam.com
Published on Oct 2014
2 Report Overview
- Scope
- - The report provides a snapshot of the global
therapeutic landscape of Constipation - - The report reviews key pipeline products under
drug profile section which includes, product
description, MoA and RD brief, licensing and
collaboration details other developmental
activities - - The report reviews key players involved in the
therapeutics development for Constipation and
enlists all their major and minor projects - - The report summarizes all the dormant and
discontinued pipeline projects - - A review of the Constipation products under
development by companies and universities/research
institutes based on information derived from
company and industry-specific sources - - Pipeline products coverage based on various
stages of development ranging from
pre-registration till discovery and undisclosed
stages - - A detailed assessment of monotherapy and
combination therapy pipeline projects - - Coverage of the Constipation pipeline on the
basis of target, MoA, route of administration and
molecule type - - Latest news and deals relating related to
pipeline products - Read More At http//www.researchbeam.com/constip
ation-pipeline-review-h2-2015-market
3 Table of Content
List of Figures Number of Products under
Development for Constipation, H2 2015 10 Number
of Products under Development for Constipation -
Comparative Analysis, H2 2015 11 Number of
Products under Development by Companies, H2 2015
12 Comparative Analysis by Late Stage
Development, H2 2015 15 Comparative Analysis by
Clinical Stage Development, H2 2015
16 Comparative Analysis by Early Stage Products,
H2 2015 17 Assessment by Monotherapy Products, H2
2015 37 Number of Products by Top 10 Targets, H2
2015 38 Number of Products by Stage and Top 10
Targets, H2 2015 38 Number of Products by Top 10
Mechanism of Actions, H2 2015 40 Number of
Products by Stage and Top 10 Mechanism of
Actions, H2 2015 40 Number of Products by Top 10
Routes of Administration, H2 2015 42 Number of
Products by Stage and Top 10 Routes of
Administration, H2 2015 42 Number of Products by
Top 10 Molecule Types, H2 2015 44 Number of
Products by Stage and Top 10 Molecule Types, H2
2015 44
4 Report Overview
Reasons to buy - Provides strategically
significant competitor information, analysis, and
insights to formulate effective RD development
strategies - Identify emerging players with
potentially strong product portfolio and create
effective counter-strategies to gain competitive
advantage - Develop strategic initiatives by
understanding the focus areas of leading
companies - Identify and understand important and
diverse types of therapeutics under development
for Constipation - Plan mergers and acquisitions
effectively by identifying key players of the
most promising pipeline - Devise corrective
measures for pipeline projects by understanding
Constipation pipeline depth and focus of
Indication therapeutics - Develop and design
in-licensing and out-licensing strategies by
identifying prospective partners with the most
attractive projects to enhance and expand
business potential and Scope - Modify the
therapeutic portfolio by identifying discontinued
projects and understanding the factors that drove
them from pipeline Enquire At
http//www.researchbeam.com/constipation-pipeline-
review-h2-2015-market/enquire-about-report
5 FOR MORE DETAILS
Visit us at
http//www.researchbeam.com/constipation-pipeline-
review-h2-2015-market
Stay With Us
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
TELEPHONE 1 (800) 910-6452 DIRECT 1 (503)
894-6022E-MAIL sales_at_researchbeam.com